Explore the Latest Patent Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Patent Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Patent Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Patent Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Patent Tenders and beyond.
13991855Announcement on the Procurement Requirements for Employee Physical Examination Service Projects of the Patent Office of the State Intellectual Property Office Patent Examination CoCountry: ChinaDeadline13 Aug 20265994719BPA - SUPPORT- PROFESSIONAL: PATENT AND TRADEMARK PSC R498Country: USADeadline11 Nov 20286890076Open house drug discount agreements Nilotinib, ATC L01EA03 (excluding Nilotinib dispersed in apple sauce, unless the manufacturer has patent protection for this)Country: GermanyDeadline05 Jan 202710903886Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for patent-protected active ingredients-VV88Country: GermanyDeadline10 Aug 202713085059Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813185742Open house drug discount agreements Eltrombopag, excl. Area of application severe aplastic anemia in the specialist information, unless the manufacturer enjoys patent protectCountry: GermanyDeadline03 Aug 202713188334Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813326147Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813347813KI-based search tool for patent scrutinyCountry: NorwayDeadline13 Sep 202613380417Open house drug discount agreements Eltrombopag, excl. Area of application severe aplastic anemia in the specialist information, unless the manufacturer enjoys patent protectCountry: GermanyDeadline03 Aug 202713414183Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813474456Open house drug discount agreements Eltrombopag, excl. Area of application severe aplastic anemia in the specialist information, unless the manufacturer enjoys patent protectCountry: GermanyDeadline03 Aug 202713481600Open house drug discount agreements Nilotinib, ATC L01EA03 (excludes Nilotinib dispersed in applesauce, unless the manufacturer enjoys patent protection for this)Country: GermanyDeadline05 Jan 202713502231Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813564960The Kinegram used is custom-designed, and OVD KINEGRAM is its exclusive manufacturer, as per patent rights. The technical parameters and method of integration with the surface haveCountry: PolandDeadline27 Sep 202613579505Open house drug discount agreements Nilotinib, ATC L01EA03 (excludes Nilotinib dispersed in applesauce, unless the manufacturer enjoys patent protection for this)Country: GermanyDeadline05 Jan 202713581538Open house drug discount agreements Eltrombopag, excl. Area of application severe aplastic anemia in the specialist information, unless the manufacturer enjoys patent protectCountry: GermanyDeadline03 Aug 202713584578Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813645248001 FA HR 0326 Unified Patent Court Pension Fund & Medical and Social Security PlanCountry: LuxembourgDeadline30 Sep 202613688094Medicinal products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Eltrombopag (patent-free indicatioCountry: GermanyDeadline05 Aug 202813725905Open house drug discount agreements Eltrombopag, excl. Area of application severe aplastic anemia in the specialist information, unless the manufacturer enjoys patent protectCountry: GermanyDeadline03 Aug 202713758302Upphandling av Patent- och immaterialrättskonsulterCountry: SwedenDeadline30 Aug 202613862787Patent filing, examination and issuanceCountry: MoldovaDeadline14 Aug 202613878198Korea Institute of Machinery and Materials selected as a patent office dedicated to technology commercialization (change notice)Country: KoreaDeadline11 Aug 202613878216Korea Institute of Machinery and Materials selected as overseas dedicated agreement patent office (change notice)Country: KoreaDeadline11 Aug 2026
